The Ministry of Health and Community Protection warned of a drug that causes difficulty breathing, swelling of the face, life threatening, and another cause of respiratory distress, requiring manufacturers to add warnings about their side effects. Healthcare practitioners should also be cautious when describing their patients.
According to Administrative Circular No. 3249 issued by Assistant Undersecretary for Public Health Policy and Licenses, Chairman of the Supreme Committee for Drug Awakening Dr. Amin Hussein Al Amiri, on the basis of a warning issued by the Food and Drug Administration regarding the use of products containing the active substance «Chlorhexidine», where It has been shown to cause severe allergic reactions, occurring within minutes of exposure. Negative symptoms include difficulty breathing, swelling of the face, severe skin rash, and may be life threatening if immediate medical care is not available.
The circular explained that there are a variety of pharmaceutical preparations containing this substance, including disinfectants, detergents, skin lotions, disinfectant mouthwashes, toothpaste, antimicrobials, dressings, eye drops, contact lens solution, urinary catheter, central vein, Take action without a prescription.
The ministry said that since the product is registered, the manufacturers of these preparations must amend the warnings and side effects in their internal bulletin to include the said subjects. Any patient facing an allergic reaction to the substance should immediately stop using them and take medical care immediately.
According to circular No. 3252 issued by the ministry, it also committed the manufacturer SANOFI to the drug
Lemtrad 12 mg solution for infusion alemtuzumac), has updated its recommendations on the use of the product, especially after the reports that have reached it after marketing it is said to cause respiratory disturbance in patients with MS within 48 hours of receiving the drug.